3 latest FDA approvals

Here are the three latest drugs approved by the Food and Drug Administration since Oct. 23.

Advertisement

1. Shingrix is a nonlive, recombinant subunit shingles vaccine for adults age 50 and older.

2. Soliris may now also be used to treat adults with generalized myasthenia gravis, an autoimmune disorder that affects the body’s intramuscular system.

3. Calquence is used to treat adults with mantle cell lymphoma after a prior treatment has failed.

More articles on supply chain:

FDA: EpiPen failures attributed to 7 deaths this year
HHS aids uninsured US Virgin Island residents in need of prescription drugs
Medline to acquire Centurion Medical Products: 4 things to know

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.